Skip to main content
OpenTrials

Clinical trial condition

Recurrent Nasal Cavity Squamous Cell Carcinoma

Explore clinical trials studying Recurrent Nasal Cavity Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Nasal Cavity Squamous Cell Carcinoma trial results

Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

NCT06980038

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +41 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Ochsner Medical Center Jefferson New Orleans, Louisiana, United States
View Trial Details

Related conditions